Intellia Therapeutics
Trade Intellia Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About NTLA
Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases.
NTLA Key Statistics
Stock Snapshot
Intellia Therapeutics(NTLA) stock is priced at $11.92, giving the company a market capitalization of 1.66B. It carries a P/E multiple of -3.36.
On 2026-07-17, Intellia Therapeutics(NTLA) stock traded between a low of $11.65 and a high of $12.85. Shares are currently priced at $11.92, which is +2.3% above the low and -7.2% below the high.
Intellia Therapeutics(NTLA) shares are trading with a volume of 6.53M, against a daily average of 5.04M.
During the past year, Intellia Therapeutics(NTLA) stock moved between $7.95 at its lowest and $28.25 at its peak.
During the past year, Intellia Therapeutics(NTLA) stock moved between $7.95 at its lowest and $28.25 at its peak.
NTLA News
The FDA’s decision to lift clinical holds on Intellia Therapeutics (NTLA)’s MAGNITUDE and MAGNITUDE-2 trials has refocused attention on the stock, as patient en...
Wolfe Research analyst Andy Chen downgraded Intellia Therapeutics (NTLA) to Underperform from Peer Perform with a $9 price target The firm said its primary conc...
Insiders have been trading these 5 stocks: ((TSE:BB)), ((SONY)), ((RUN)), ((CRDO)) and ((NTLA)). Here is a breakdown of their recent trades and their value. Bl...
Analyst ratings
50%
of 20 ratingsMore NTLA News
Wedbush raised the firm’s price target on Intellia Therapeutics to $17 from $12 and keeps a Neutral rating on the shares. Relevant to Intellia Therapeutics (NTL...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.